IOBT

0.8745

6.65% 0.0545

Handel nachbörslich: .87 -0.0045 -0.51%

Io Biotech Inc (IOBT)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Schlusskurs vom Vortag:

$0.82

Offen:

$0.8314

24-Stunden-Volumen:

216.27K

Relative Volume:

0.47

Marktkapitalisierung:

$58.71M

Einnahmen:

Nettoeinkommen (Verlust:

$-86.08M

KGV:

-0.3403

EPS:

-2.57

Netto-Cashflow:

$-72.06M

1W Leistung:

-16.71%

1M Leistung:

-29.48%

6M Leistung:

-36.63%

1J Leistung:

-12.05%

1-Tages-Spanne:

$0.82

$0.9799

1-Wochen-Bereich:

$0.79

$1.04

52-Wochen-Spanne:

$0.7327

$2.098

Io Biotech Inc Stock (IOBT) Company Profile

Firmenname

Io Biotech Inc

Sektor

Healthcare (1196)

Branche

Biotechnology (683)

Telefon

(457) 070-2980

Adresse

OLE MAALOES VEH 3, COPENHAGEN

Mitarbeiter

Twitter

Nächster Verdiensttermin

Neueste SEC-Einreichungen

IOBT's Discussions on Twitter

Vergleichen Sie IOBT mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
IOBT	0.8745	58.71M	0	-86.08M	-72.06M	-2.57
VRTX	467.01	119.87B	10.63B	-479.80M	-1.35B	13.33
REGN	762.00	83.27B	13.85B	4.65B	3.32B	35.06
ARGX	567.90	33.96B	1.86B	-40.29M	-1.28B	-4.16
ALNY	232.27	30.18B	2.09B	-332.26M	16.06M	-4.14
BNTX	101.87	24.42B	3.30B	-501.07M	1.03B	11.54

Io Biotech Inc Aktie (IOBT) Neueste Nachrichten

Nov 15, 2024

HC Wainwright Decreases Earnings Estimates for IO Biotech - MarketBeat

Nov 15, 2024

Nov 13, 2024

Neuronetics (NASDAQ: STIM) Announces Key Financial Updates and FDA Clearance for Adolescent Treatment - Defense World

Nov 13, 2024

Nov 12, 2024

IO Biotech (NASDAQ:IOBT) Given "Buy" Rating at HC Wainwright - MarketBeat

Nov 12, 2024

IO Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 12, 2024

Celcuity Inc. To Present at Upcoming Stifel and Jefferies Investor Conferences - The Manila Times

Nov 12, 2024

IO Biotech Reports Advancing Cancer Trials Despite Widening Q3 Losses; Cash Position at $80.2M | IOBT Stock News - StockTitan

Nov 12, 2024

Nov 11, 2024

IO Biotech Announces Participation in Upcoming Investor Conferences - Marketscreener.com

Nov 11, 2024

IO Biotech to Present at Jefferies, Piper Sandler Healthcare Conferences | IOBT Stock News - StockTitan

Nov 11, 2024

Nov 10, 2024

Asia stocks fall as China stimulus disappoints, deflation persists - Investing.com

Nov 10, 2024

Nov 08, 2024

IO Biotech, Inc. Announces Data from the NSCLC Cohort in the Phase 2 Basket Trial of IO102-IO103 - Marketscreener.com

Nov 08, 2024

Promising results for IO Biotech’s cancer vaccine By Investing.com - Investing.com Canada

Nov 08, 2024

Nov 07, 2024

IO Biotech Reports its Off-the-Shelf Therapeutic Cancer Vaccine, IO102-IO103, in Combination with KEYTRUDA® Demonstrates Promising Activity and Durability in First-line Treatment of Patients with Metastatic Lung Cancer in Phase 2 IOB-022 Study - ForexTV.com

Nov 07, 2024

IO Biotech's Cancer Vaccine Shows 81% Disease Control Rate in Lung Cancer Trial | IOBT Stock News - StockTitan

Nov 07, 2024

Nov 03, 2024

Here's Why We're A Bit Worried About IO Biotech's (NASDAQ:IOBT) Cash Burn Situation - Yahoo Finance

Nov 03, 2024

Oct 30, 2024

Legend Biotech Chooses Philadelphia for New R&D Center - BioBuzz

Oct 30, 2024

Oct 29, 2024

Short Interest in IO Biotech, Inc. (NASDAQ:IOBT) Declines By 12.7% - MarketBeat

Oct 29, 2024

Oct 28, 2024

Melanoma Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers - The Globe and Mail

Oct 28, 2024

Oct 27, 2024

Melanoma Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therapies, Treatment Market, MOA, ROA, Companies by DelveInsight - Barchart

Oct 17, 2024

Oct 13, 2024

38,076 Shares in Montauk Renewables, Inc. (NASDAQ:MNTK) Bought by Squarepoint Ops LLC - Defense World

Oct 13, 2024

Bank of America Boosts Voya Financial (NYSE:VOYA) Price Target to $88.00 - Defense World

Oct 13, 2024

Oct 11, 2024

IO Biotech, Inc. (NASDAQ:IOBT) Short Interest Update - MarketBeat

Oct 11, 2024

Norstella introduces a fully integrated data asset for biopharma - European Pharmaceutical Manufacturer

Oct 11, 2024

Immuno-Oncology Clinical Trials Market Valuation to Reach $18.1 Billion By 2032 - 대구포스트

Oct 11, 2024

Oct 05, 2024

IO Biotech Announces Two Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting - ForexTV.com

Oct 05, 2024

Oct 04, 2024

VerImmune Secures $4.5 Million to Drive Biotech Innovation - BioBuzz

Oct 04, 2024

IO Biotech Announces Two Poster Presentations at the Society for Immunotherapy of Cancer's (SITC) 39th Annual Meeting - The Manila Times

Oct 04, 2024

ARHT Media Inc. Announces Filing for Bankruptcy - The Manila Times

Oct 04, 2024

IO Biotech Announces Two Poster Presentations at the Society for Immunotherapy of Cancer's 39th Annual Meeting - Marketscreener.com

Oct 04, 2024

Oct 03, 2024

United States shares lower at close of trade; Dow Jones Industrial Average down 1.51% - MSN

Oct 03, 2024

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.51% - MSN

Oct 03, 2024

Tesla Inc (TSLA-Q) QuotePress Release - The Globe and Mail

Oct 03, 2024

Oct 01, 2024

5 Best Stem Cell Companies to Invest In (November 2024) - Securities.io

Oct 01, 2024

Sep 30, 2024

ProShare Advisors LLC Sells 113 Shares of Reinsurance Group of America, Incorporated (NYSE:RGA) - Defense World

Sep 30, 2024

Novo Holdings A S Sells 658,809 Shares of IO Biotech, Inc. (NASDAQ:IOBT) - MarketBeat

Sep 30, 2024

American Century Companies Inc. Purchases 75,475 Shares of Lifetime Brands, Inc. (NASDAQ:LCUT) - Defense World

Sep 30, 2024

Sep 27, 2024

PCI Pharma Services invests over $365 million in EU and US facilities - European Pharmaceutical Manufacturer

Sep 27, 2024

Sep 26, 2024

Sei Investments Co. Buys 24,363 Shares of IQVIA Holdings Inc. (NYSE:IQV) - Defense World

Sep 26, 2024

Cancer Vaccines Market Detailed In Recent Development to Grow - openPR

Sep 26, 2024

Sep 23, 2024

Up 41% YTD, This Standout Growth Stock Has More Upside Ahead - The Globe and Mail

Sep 23, 2024

Sep 20, 2024

U.S. shares lower at close of trade; Dow Jones Industrial Average down 1.51% - MSN

Sep 20, 2024

Sep 18, 2024

Investors in cash trouble should check out IO Biotech Inc (IOBT) - SETE News

Sep 18, 2024

Why Intuitive Machines Shares Are Trading Higher By Around 41%; Here Are 20 Stocks Moving Premarket - Benzinga

Sep 18, 2024

IO Biotech (NASDAQ:IOBT) Rating Reiterated by HC Wainwright - Defense World

Sep 18, 2024

IO Biotech (NASDAQ:IOBT) PT Raised to $6.00 - Defense World

Sep 18, 2024

Sep 17, 2024